NGF and BDNF signaling control amyloidogenic route and Aβ production in hippocampal neurons
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Here, we report that interruption of NGF or BDNF signaling in hippocampal neurons rapidly activates the amyloidogenic pathway and causes neuronal apoptotic death. These events are associated with an early intracellular accumulation of PS1 N-terminal catalytic subunits and of APP C-terminal fragments and a progressive accumulation of intra- and extracellular Aβ aggregates partly released into the culture medium. The released pool of Aβ induces an increase of APP and PS1 holoprotein levels, creating a feed-forward toxic loop that might also cause the death of healthy neurons. These events are mimicked by exogenously added Aβ and are prevented by exposure to β- and γ-secretase inhibitors and by antibodies directed against Aβ peptides. The same cultured neurons deprived of serum die, but APP and PS1 overexpression does not occur, Aβ production is undetectable, and cell death is not inhibited by anti-Aβ antibodies, suggesting that hippocampal amyloidogenesis is not a simple consequence of an apoptotic trigger but is due to interruption of neurotrophic signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“A study suggested that impaired BDNF nutritional signaling also stimulated the expression of APP and PS1 to exacerbate amyloidogenesis.352”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [352]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104 · cited 3×
“(2008) Beta-amyloid(1-42) induces neuronal death through the p75 neurotrophin receptor.”
BackgroundA phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease
Tuszynski, M. H., Thal, L., Pay, M., Salmon, D. P., U, H. S., Bakay, R., Patel, P., Blesch, A., Vahlsing, H. L., Ho, G., et al. (2005) · Nature Medicine · doi:10.1038/nm1239 · Cited by 1,050 · cited 3×
“(2008) Beta-amyloid(1-42) induces neuronal death through the p75 neurotrophin receptor.”
BackgroundSalehi, A., Delcroix, J.-D., Belichenko, P. V., Zhan, K., Wu, C., Valletta, J. S., Takimoto-Kimura, R., Kleschevnikov, A. M., Sambamurti, K., Chung, P. P., et al. (2006) · Neuron · doi:10.1016/j.neuron.2006.05.022 · Cited by 543 · cited 3×
“(2008) Beta-amyloid(1-42) induces neuronal death through the p75 neurotrophin receptor.”
BackgroundThe role of neuronal growth factors in neurodegenerative disorders of the human brain
Connor, B., & Dragunow, M. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00004-6 · Cited by 536 · cited 3×
“(2008) Beta-amyloid(1-42) induces neuronal death through the p75 neurotrophin receptor.”
BackgroundNeurotrophic factors in Alzheimer’s and Parkinson’s disease brain
Siegel, G. J., & Chauhan, N. B. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00030-8 · Cited by 496
Cooper, J. D., Salehi, A., Delcroix, J.-D., Howe, C. L., Belichenko, P. V., Chua-Couzens, J., Kilbridge, J. F., Carlson, E. J., Epstein, C. J., & Mobley, W. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181219298 · Cited by 336 · cited 3×
“(2008) Beta-amyloid(1-42) induces neuronal death through the p75 neurotrophin receptor.”
BackgroundClinical relevance of the neurotrophins and their receptors
Allen, S. J., & Dawbarn, D. (2006) · Clinical Science · doi:10.1042/cs20050161 · Cited by 320 · cited 4×
“(2008) Beta-amyloid(1-42) induces neuronal death through the p75 neurotrophin receptor.”
BackgroundInfluentialAlzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice
Capsoni, S., Ugolini, G., Comparini, A., Ruberti, F., Berardi, N., & Cattaneo, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.12.6826 · Cited by 277
Rajagopal, R., Chen, Z.-Y., Lee, F. S., & Chao, M. V. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0010-04.2004 · Cited by 257 · cited 4×
“The presence of the active (pTrKA) receptor in hippocampal neurons incubated with ( NGF) or without NGF ( NGF) for 48 h was verified by Western blot analysis using selective anti-popsho TrKA antibody kindly provided by M. Chao (New York University, New York) (22).”
BackgroundInfluentialβ-Amyloid1–42Induces Neuronal Death through the p75 Neurotrophin Receptor
Sotthibundhu, A., Sykes, A. M., Fox, B., Underwood, C. K., Thangnipon, W., & Coulson, E. J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0350-08.2008 · Cited by 236 · cited 3×
“(2008) Beta-amyloid(1-42) induces neuronal death through the p75 neurotrophin receptor.”
Background
Cited by
Miranda, M., Morici, J. F., Zanoni, M. B., & Bekinschtein, P. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00363 · Cited by 1,416
“…regime can lessen the accumulation of oxidative cell damage and the dysfunction characteristic of aged animals (Radak et al., 2001), and selective suppression of BDNF increases the vulnerability of neurons to excitotoxicity (Jiang et al., 2005) and increases amyloidogenesis (Matrone et al., 2008).”
BackgroundZhang, J., Zhang, Y., Wang, J., Xia, Y., Zhang, J., & Chen, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01911-3 · Cited by 1,138
RETRACTED ARTICLE: APP binds DR6 to trigger axon pruning and neuron death via distinct caspases
Nikolaev, A., McLaughlin, T., O’Leary, D. D. M., & Tessier-Lavigne, M. (2009) · Nature · doi:10.1038/nature07767 · Cited by 992
RetractedBrain-Derived Neurotrophic Factor in Alzheimer’s Disease and Its Pharmaceutical Potential
Gao, L., Zhang, Y., Sterling, K., & Song, W. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00279-0 · Cited by 606
“In turn, the interruption of BDNF signaling triggers hippocampal amyloidogenesis by promoting the accumulation of PS1 N-terminal catalytic subunits, APP C-terminal fragments, and abnormal aggregation of Aβ [205].”
BackgroundTau Protein Modifications and Interactions: Their Role in Function and Dysfunction
Mietelska-Porowska, A., Wasik, U., Goras, M., Filipek, A., & Niewiadomska, G. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15034671 · Cited by 404
Shen, X.-N., Niu, L.-D., Wang, Y.-J., Cao, X.-P., Liu, Q., Tan, L., Zhang, C., & Yu, J.-T. (2019) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2018-319148 · Cited by 388
“and function maintenance, and its deficiency leads to increasing production of Aβ aggregates and neuron death.(33)”
BackgroundGarcía-Ayllón, M.-S. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00022 · Cited by 299
“A vicious cycle of Aβ generation potentially could involve PS1; recent evidence indicates that Aβ42 can induce an increase in PS1 levels in cultured neurons creating a toxic loop (Matrone et al., 2008).”
BackgroundWang, Z.-H., Xiang, J., Liu, X., Yu, S. P., Manfredsson, F. P., Sandoval, I. M., Wu, S., Wang, J.-Z., & Ye, K. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.06.054 · Cited by 238
“The specificity of this antibody has previously been demonstrated (Matrone et al., 2008), and a recent study uses it in rat brain (Lambert et al., 2017).”
Cdk5: a multifaceted kinase in neurodegenerative diseases
Cheung, Z. H., & Ip, N. Y. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.11.003 · Cited by 233
Pinton, S., Sampaio, T., Savall, A., & Gutierrez, M. Z. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.205084 · Cited by 219
“Indeed, there are in vitro and in vivo evidence suggesting that NGF levels control the amyloidogenic pathway and β-amyloid peptides production (Matrone et al., 2008a, b; Yang et al., 2014).”
BackgroundExercise and BDNF reduce Aβ production by enhancing α‐secretase processing of APP
Nigam, S. M., Xu, S., Kritikou, J. S., Marosi, K., Brodin, L., & Mattson, M. P. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14034 · Cited by 185
“2009) and that inhibition of BDNF signaling increases Ab generation (Matrone et al. 2008).”
BackgroundRothman, S. M., & Mattson, M. P. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2012.10.014 · Cited by 183
“For example, selective suppression of BDNF production or trkBmediated BDNF signaling increases the vulnerability of neurons to excitotoxicity (Jiang et al., 2005) and promotes amyloidogenic APP processing (Matrone et al., 2008).”
Human neural stem cells alleviate Alzheimer-like pathology in a mouse model
Lee, I.-S., Jung, K., Kim, I.-S., Lee, H., Kim, M., Yun, S., Hwang, K., Shin, J. E., & Park, K. I. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0035-6 · Cited by 167
“Recently, some studies describe that trophic factors, especially BDNF directly control tau phosphorylation and Aβ production [46, 51].”
Gupta, V., You, Y., Li, J., Gupta, V. B., Golzan, M., Klistorner, A. I., van den Buuse, M., & Graham, S. L. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.05.026 · Cited by 158
“Interruption of BDNF signalling has previously been shown to rapidly activate amyloidogenic pathways and exacerbate Aβ production causing neuronal apoptotic death in the hippocampal neurons [41].”
BackgroundProNGF and Neurodegeneration in Alzheimer’s Disease
Fahnestock, M., & Shekari, A. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00129 · Cited by 126
Brain-Derived Neurotropic Factor in Neurodegenerative Disorders
Ibrahim, A. M., Chauhan, L., Bhardwaj, A., Sharma, A., Fayaz, F., Kumar, B., Alhashmi, M., Alhajri, N., Alam, M. S., & Pottoo, F. H. (2022) · Biomedicines · doi:10.3390/biomedicines10051143 · Cited by 142
Rohe, M., Synowitz, M., Glass, R., Paul, S. M., Nykjaer, A., & Willnow, T. E. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3960-09.2009 · Cited by 122
“In these experiments, blockade of BDNF signaling by anti-BDNF antibodies increased A formation and accumulation in neurons, and resulted in induction of neuronal cell death (Matrone et al., 2008).”
BackgroundThe putative neurodegenerative links between depression and Alzheimer's disease
Wuwongse, S., Chang, R. C., & Law, A. C. K. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.04.005 · Cited by 134
“In AD, disruption in the neurotrophic factor BDNF signaling has been shown to promote the amyloidogenic pathway in hippocampal neurons, subsequently leading to the activation of apoptosis (Matrone et al., 2008).”
He, P., Yan, S., Zheng, J., Gao, Y., Zhang, S., Liu, Z., Liu, X., & Xiao, C. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b03731 · Cited by 125
Markham, A., Bains, R., Franklin, P., & Spedding, M. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12531 · Cited by 111
“2214 British Journal of Pharmacology (2014) 171 2206–2229 activity was blocked by trkB-Fc fusion protein (Matrone et al., 2008).”
BackgroundApoptosis and in vitro Alzheimer’s disease neuronal models
Calissano, P., Matrone, C., & Amadoro, G. (2009) · Communicative & Integrative Biology · doi:10.4161/cib.7704 · Cited by 119
Self-citationNumakawa, T., & Odaka, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115719 · Cited by 112
“In the primary culture of hippocampal neurons, a deprivation of NGF or BDNF induces Aβ production via upregulation of amyloidogenic pathway components, APP, presenilin-1 [55].”
BackgroundRodrigues, R., Petersen, R. B., & Perry, G. (2014) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-014-0074-5 · Cited by 99
“…to cyclic AMP response element binding protein and stimulating DNA synthesis (Caccamo et al. 2010) through control of the amyloidogenic pathway and Aβ production in hippocampal neurons (Matrone et al. 2008) and through stimulating neural stem cells to improve cognition (Blurton-Jones et al. 2009).”
Capsoni, S., Covaceuszach, S., Marinelli, S., Ceci, M., Bernardo, A., Minghetti, L., Ugolini, G., Pavone, F., & Cattaneo, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017321 · Cited by 98
“The neurotrophic and neuroprotective properties of hNGF and hNGFR100E mutants were then compared in a neuronal amyloidogenic model”
BackgroundFerreira, J. P. S., Albuquerque, H. M. T., Cardoso, S. M., Silva, A. M. S., & Silva, V. L. M. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113492 · Cited by 96
Zhang, M., Zheng, C.-Y., Zou, M., Zhu, J.-W., Zhang, Y., Wang, J., Liu, C., Li, Q., Xiao, Z., Li, S., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.06.009 · Cited by 98
Nerve Growth Factor and Alzheimer's Disease: New Facts for an Old Hypothesis
Cattaneo, A., & Calissano, P. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8310-9 · Cited by 101
“In this context, it is worth noting that also BDNF appears to keep the amyloidogenic pathway under control since its withdrawal from target neurons is accompanied by overproduction of Aβ [69], suggesting that the concept of NGF trophic action as an anti-amyloidogenic action could be extended to other neurotrophins as…”
BackgroundResultSelf-citationDevi, L., & Ohno, M. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.55 · Cited by 92
Nerve growth factor as a paradigm of neurotrophins related to Alzheimer's disease
Calissano, P., Matrone, C., & Amadoro, G. (2010) · Developmental Neurobiology · doi:10.1002/dneu.20759 · Cited by 86
“We observe that an early, transient and site-specific GSK-3b-mediated tau hyperphosphorylation (3–6 h after NGF withdrawal)—at two AD-relevant pathological epitopes (Ser262 and Thr231)—is temporally and causally related with an activation of the endogenous amyloidogenic pathway in NGF-deprived hippocampal primary neur…”
BackgroundInfluentialSelf-citationFyn Tyrosine Kinase as Harmonizing Factor in Neuronal Functions and Dysfunctions
Matrone, C., Petrillo, F., Nasso, R., & Ferretti, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124444 · Cited by 88
Self-citationAlzheimer's Disease and Amyloid: Culprit or Coincidence?
Skaper, S. D. (2012) · International review of neurobiology · doi:10.1016/b978-0-12-386986-9.00011-9 · Cited by 91
“This model provided evidence correlating NGF deprivation and Ab accumulation (Matrone et al., 2008; Nikolaev et al., 2009).”
BackgroundFaustino, C. M. C., Rijo, P. M., & Reis, C. P. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.03.020 · Cited by 87
Capsoni, S., Tiveron, C., Vignone, D., Amato, G., & Cattaneo, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007181107 · Cited by 81
“Capsoni S, Giannotta S, Cattaneo A (2002) Beta-amyloid plaques in a model for sporadic Alzheimer’s disease based on transgenic anti-nerve growth factor antibodies.”
BackgroundInfluentialZhong, Y., Chen, J., Li, L., Qin, Y., Wei, Y., Pan, S., Jiang, Y., Chen, J., & Xie, Y. (2018) · Brain Research · doi:10.1016/j.brainres.2018.04.022 · Cited by 83
“Covincing evidence point out that interruption of NGF-BDNF signaling in hippocampal neurons could cause neuronal apoptotic death (Matrone et al, 2008).”
BackgroundCapsoni, S., Marinelli, S., Ceci, M., Vignone, D., Amato, G., Malerba, F., Paoletti, F., Meli, G., Viegi, A., Pavone, F., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037555 · Cited by 74
Jaberi, S., & Fahnestock, M. L. (2023) · Biomolecules · doi:10.3390/biom13111577 · Cited by 84
Endogenous Aβ causes cell death via early tau hyperphosphorylation
Amadoro, G., Corsetti, V., Ciotti, M. T., Florenzano, F., Capsoni, S., Amato, G., & Calissano, P. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.06.005 · Cited by 89
Self-citationOligodendroglia and neurotrophic factors in neurodegeneration
Bankston, A. N., Mandler, M. D., & Feng, Y. (2013) · Neuroscience Bulletin · doi:10.1007/s12264-013-1321-3 · Cited by 70
Johnson, M. (2012) · Materials and Methods · doi:10.13070/mm.en.2.113 · Cited by 92
Arora, S., Kanekiyo, T., & Singh, J. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.03.203 · Cited by 67
Aneuploidy, chromosomal missegregation, and cell cycle reentry in Alzheimer's disease
Zekanowski, C., & Wojda, U. (2009) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2009-1748 · Cited by 73
“Matrone C, Ciotti MT, Mercanti D, Marolda R, Calissano P (2008) NGF and BDNF signaling control amyloidogenic route and Abeta production in hippocampal neurons.”
BackgroundTriaca, V., Sposato, V., Bolasco, G., Ciotti, M. T., Pelicci, P., Bruni, A. C., Cupidi, C., Maletta, R., Feligioni, M., Nisticò, R., et al. (2016) · Aging Cell · doi:10.1111/acel.12473 · Cited by 73
“Moreover, in vitro models of NGF deprivation show that amyloid accumulation is induced and AD pathology is mimicked in PC12 and hippocampal neurons (Matrone et al., 2008a,b); this has been referred to as ‘Alzheimer’s-like molecular syndrome’ (Calissano et al., 2010).”
BackgroundMethodSelf-citationIshola, I. O., Osele, M. O., Chijioke, M. C., & Adeyemi, O. O. (2019) · Brain Research · doi:10.1016/j.brainres.2019.02.017 · Cited by 76
Antidepressants are a rational complementary therapy for the treatment of Alzheimer's disease
Aboukhatwa, M., Dosanjh, L., & Luo, Y. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-10 · Cited by 69
“larly and extracellularly [151].”
Xhima, K., Markham-Coultes, K., Nedev, H., Heinen, S., Saragovi, H. U., Hynynen, K., & Aubert, I. (2020) · Science Advances · doi:10.1126/sciadv.aax6646 · Cited by 69
Ginsberg, S. D., Malek-Ahmadi, M. H., Alldred, M. J., Chen, Y., Chen, K., Chao, M. V., Counts, S. E., & Mufson, E. J. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104540 · Cited by 70
“Rather, a growing number of studies using relevant AD animal and cellular models suggests amyloid-β precursor protein (APP) and its metabolites, including amyloid-β peptide (Aβ) downregulates BDNF expression and BDNF-TrkB retrograde trafficking (Garzon and Fahnestock, 2007; Peng et al., 2009; Poon et al., 2011, 2013),…”
BackgroundThe Emerging Therapeutic Role of NGF in Alzheimer’s Disease
Xu, C., Wang, J., & Jin, W. (2016) · Neurochemical Research · doi:10.1007/s11064-016-1829-9 · Cited by 75
Canu, N., Amadoro, G., Triaca, V., Latina, V., Sposato, V., Corsetti, V., Severini, C., Ciotti, M. T., & Calissano, P. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061319 · Cited by 71
“Such death promoting agents, albeit acting via different mechanisms, make TrkA/APP complexes sensitive to cell death stimuli associated with amyloidogenic APP processing, which also occurs in NGF-deprived primary hippocampal neurons [39].”
BackgroundResultSelf-citationMatrone, C., Marolda, R., Ciafrè, S., Ciotti, M. T., Mercanti, D., & Calissano, P. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904998106 · Cited by 73
“Sotthibundhu A, et al. (2008) Beta-amyloid(1-42) induces neuronal death through the p75 neurotrophin receptor.”
BackgroundSelf-citationXiang, J., Wang, Z.-H., Ahn, E. H., Liu, X., Yu, S.-P., Manfredsson, F. P., Sandoval, I. M., Ju, G., Wu, S., & Ye, K. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1901348116 · Cited by 67
“As BDNF withdrawal also induces Aβ production (28), we also monitored Aβ IHC activity with anti-Aβ (6E10).”
BackgroundMethodLow molecular weight, non-peptidic agonists of TrkA receptor with NGF-mimetic activity
Scarpi, D., Cirelli, D., Matrone, C., Castronovo, G., Rosini, P., Occhiato, E. G., Romano, F., Bartali, L., Clemente, A. M., Bottegoni, G., et al. (2012) · Cell Death & Disease · doi:10.1038/cddis.2012.80 · Cited by 67
Self-citationNanoparticle-mediated growth factor delivery systems: A new way to treat Alzheimer's disease
Lauzon, M.-A., Daviau, A., Marcos, B., & Faucheux, N. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.03.024 · Cited by 68
Liu, Z., Chen, Y., Qiao, Q., Sun, Y., Liu, Q., Ren, B., & Liu, X. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600734 · Cited by 67
Belviranlı, M., & Okudan, N. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.02.030 · Cited by 68
APP is Phosphorylated by TrkA and Regulates NGF/TrkA Signaling
Matrone, C., Barbagallo, A. P. M., La Rosa, L. R., Florenzano, F., Ciotti, M. T., Mercanti, D., Chao, M. V., Calissano, P., & D'Adamio, L. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.1960-11.2011 · Cited by 61
“The finding that interruption of NGF signaling in hippocampal neurons rapidly activates APP processing and causes neuronal apoptotic death further supported this link (Matrone et al., 2008, 2009).”
BackgroundMethodResultSelf-citationThe Role of the p75 Neurotrophin Receptor in Cholinergic Dysfunction in Alzheimer's Disease
Coulson, E. J., May, L. M., Sykes, A. M., & Hamlin, A. S. (2009) · The Neuroscientist · doi:10.1177/1073858408331376 · Cited by 61
Montalban, E., Mattugini, N., Ciarapica, R., Provenzano, C., Savino, M., Scagnoli, F., Prosperini, G., Carissimi, C., Fulci, V., Matrone, C., et al. (2014) · NeuroMolecular Medicine · doi:10.1007/s12017-014-8292-z · Cited by 56
“Following Ngf deprivation, terminally differentiated PC12 cells show an increase in the amount of App protein (Matrone et al. 2008b).”
BackgroundMethodInfluentialSelf-citationThe entorhinal cortex and neurotrophin signaling in Alzheimer’s disease and other disorders
Scharfman, H. E., & Chao, M. V. (2013) · Cognitive Neuroscience · doi:10.1080/17588928.2013.826184 · Cited by 58
“NGF (and BDNF) are also potentially important to the metabolism of APP, and therefore the production of Aβ because removal of NGF and BDNF increased cleavage of APP in cell culture (Matrone et al., 2008; Nikolaev et al., 2009).”
BackgroundLatina, V., Caioli, S., Zona, C., Ciotti, M. T., Amadoro, G., & Calissano, P. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00068 · Cited by 56
“…of tau are also detected in animal and cellular neuronal models undergoing NGF withdrawal which recapitulate a comprehensive AD-like neuropathology (Capsoni et al., 2000; Ruberti et al., 2000; Matrone et al., 2008a,b; Houeland et al., 2010; Amadoro et al., 2011; Triaca et al., 2016).”
BackgroundInfluentialSelf-citationIntranasal delivery of BDNF rescues memory deficits in AD11 mice and reduces brain microgliosis
Braschi, C., Capsoni, S., Narducci, R., Poli, A., Sansevero, G., Brandi, R., Maffei, L., Cattaneo, A., & Berardi, N. (2021) · Aging Clinical and Experimental Research · doi:10.1007/s40520-020-01646-5 · Cited by 48
Wang, Z.-H., Wu, W., Kang, S. S., Liu, X., Wu, Z., Peng, J., Yu, S. P., Manfredsson, F. P., Sandoval, I. M., Liu, X., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.99007 · Cited by 51
“Consistently with this notion, BDNF reduces Aβ levels in vitro and in vivo and BDNF deprivation elevates Aβ production (27, 53, 54).”
BackgroundPellitteri, R., Spatuzza, M., Russo, A., Zaccheo, D., & Stanzani, S. (2009) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2009.05.001 · Cited by 55
Targeting both BDNF/TrkB pathway and delta-secretase for treating Alzheimer's disease
Liao, J., Chen, C., Ahn, E. H., Liu, X., Li, H., Edgington-Mitchell, L. E., Lu, Z., Ming, S., & Ye, K. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108737 · Cited by 49
Alzheimer’s Disease, Neural Plasticity, and Functional Recovery
Mercerón‐Martínez, D., Ibaceta-González, C., Salazar, C., Almaguer‐Melian, W., Bergado, J. A., & Palacios, A. G. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201178 · Cited by 54
Pirhaghi, M., Mamashli, F., Moosavi-Movahedi, F., Arghavani, P., Amiri, A., Davaeil, B., Mohammad-Zaheri, M., Mousavi-Jarrahi, Z., Sharma, D., Langel, Ü., et al. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.3c01167 · Cited by 51
Han, J., Hyun, J., Park, J., Jung, S., Oh, Y., Kim, Y., Ryu, S.-H., Kim, S., Jeong, E. I., Jo, D., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110102 · Cited by 51
Choi, G.-Y., Kim, H.-B., Hwang, E., Park, H.-S., Cho, J.-M., Ham, Y.-K., Kim, J. H., Mun, M.-K., Maeng, S., & Park, J. H. (2022) · NeuroToxicology · doi:10.1016/j.neuro.2022.12.007 · Cited by 47
Houeland, G., Romani, A., Marchetti, C., Amato, G., Capsoni, S., Cattaneo, A., & Marie, H. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0457-10.2010 · Cited by 46
Key Role of Mitochondria in Alzheimer’s Disease Synaptic Dysfunction
Cavallucci, V., Ferraina, C., & D'Amelio, M. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319360005 · Cited by 47
“The interruption of NGF or BDNF signaling in cultured hippocampal neurons activates the amyloidogenic pathway with a progressive accumulation of intracellular and extracellular A aggregates, and induces apoptosis [182], suggesting that NTs may regulate A production.”
BackgroundEggert, S., Kins, S., Endres, K., & Brigadski, T. (2022) · Biological Chemistry · doi:10.1515/hsz-2021-0330 · Cited by 46
“Furthermore, BDNF deprivation enhanced A β content in extracellular medium of hippocampal and cortical cultures (Matrone et al. 2008; Wang et al. 2019), and levels of BDNF mRNA negatively correlated with the ratio of A β 42/A β 40 in three transgenic AD mouse strains (Peng et al. 2009).”
BackgroundLigand-Dependent TrkA Activity in Brain Differentially Affects Spatial Learning and Long-Term Memory
Aboulkassim, T., Tong, X., Tse, Y. C., Wong, T. P., Woo, S. B., Neet, K., Brahimi, F., Hamel, É., & Saragovi, H. U. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.071332 · Cited by 48
Inhalational Alzheimer's disease: an unrecognized—and treatable—epidemic
Bredesen, D. E. (2016) · Aging · doi:10.18632/aging.100896 · Cited by 50
“In contrast, Aβ is also produced in response to the withdrawal of trophic support [11], and indeed APP processing to Aβ peptides is influenced by factors involved in trophic support, such as estradiol and SirT1.”
BackgroundPediaditakis, I., Efstathopoulos, P., Prousis, K. C., Zervoú, M., Arévalo, J. C., Alexaki, V. I., Nikoletopoulou, V., Karagianni, E., Potamitis, C., Tavernarakis, N., et al. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.09.007 · Cited by 50
“A growing number of published experimental and clinical protocols evaluating the utilization of NGF in the armamentarium against neurodegenerative diseases both as preventive or therapeutic agent acting as neural tissue protector and/or repairer of neuronal deficits (Calissano et al., 2010; Matrone et al., 2008).”
Ari, C., Borysov, S. I., Wu, J., Padmanabhan, J., & Potter, H. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.02.006 · Cited by 49
Chiu, Y., Teng, Y.-S., Chen, C., Sun, Y., Hsieh‐Li, H. M., Chang, K., & Lee‐Chen, G. (2023) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2022.136 · Cited by 45
Matrone, C., Luvisetto, S., La Rosa, L. R., Tamayev, R., Pignataro, A., Canu, N., Yang, L., Barbagallo, A. P. M., Biundo, F., Lombino, F., et al. (2012) · Aging Cell · doi:10.1111/acel.12009 · Cited by 43
“Additionally, an intimate crosstalk between APP and NGF pathways has been described, and Y682 plays a central role in this functional relationship (Matrone et al., 2008, 2009, 2011; Calissano et al., 2010). ª 2012 The Authors Aging Cell ª 2012 Blackwell Publishing Ltd/Anatomical Society of Great…”
BackgroundSelf-citationNanoneuromedicine for management of neurodegenerative disorder
Dwivedi, N., Shah, J., Mishra, V. K., Tambuwala, M. M., & Kesharwani, P. (2018) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2018.12.021 · Cited by 46
Alzheimer’s Disease and Protein Kinases
Engin, A. B., & Engin, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-49844-3_11 · Cited by 48
Withdrawal of BDNF from hippocampal cultures leads to changes in genes involved in synaptic function
Mariga, A., Zavadil, J., Ginsberg, S. D., & Chao, M. V. (2015) · Developmental Neurobiology · doi:10.1002/dneu.22216 · Cited by 43
“This is sup- ported by previous studies that demonstrated that NGF withdrawal is linked to changes in APP metabo- lism (Matrone et al., 2008; Nikolaev et al., 2009).”
MethodChen, C., Ahn, E. H., Liu, X., Wang, Z.-H., Luo, S., Liao, J., & Ye, K. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00181 · Cited by 41
Endogenous amyloidogenesis in long-term rat hippocampal cell cultures
Bertrand, S. J., Aksenova, M. V., Aksenov, M. Y., Mactutus, C. F., & Booze, R. M. (2011) · BMC Neuroscience · doi:10.1186/1471-2202-12-38 · Cited by 40
“The excessive release of Ab from cultured rat hippocampal neurons can result in the increase of amyloid-binding dye fluorescence in the culture medium and Ab-mediated toxicity [30].”
BackgroundFinding memo: versatile interactions of the VPS10p-Domain receptors in Alzheimer’s disease
Salasova, A., Monti, G., Andersen, O. M., & Nykjaer, A. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00576-2 · Cited by 42
Reveglia, P., Paolillo, C., Ferretti, G., Carlo, A. D., Angiolillo, A., Nasso, R., Caputo, M., Matrone, C., Costanzo, A. D., & Corso, G. (2021) · Metabolomics · doi:10.1007/s11306-021-01828-w · Cited by 50
Self-citationLefort, R., Pozueta, J., & Shelanski, M. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.6473-11.2012 · Cited by 37
“…undergoing apoptosis have been shown to overproduce and secrete A , whether triggered by staurosporine or by trophic factor withdrawal (LeBlanc, 1995; Barnes et al., 1998; Galli et al., 1998; Gervais et al., 1999; Guo et al., 2001; Tesco et al., 2003; Sodhi et al., 2004; Matrone et al., 2008a,b).”
BackgroundXia, Y., Wang, Z.-H., Liu, P., Edgington‐Mitchell, L. E., Liu, X., Wang, X., & Ye, K. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-00863-8 · Cited by 41
Castello, N. A., Green, K. N., & LaFerla, F. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039566 · Cited by 36
“. It was recently reported that treatment of cultured hippocampal neurons with anti-BDNF antibodies induces amyloidogenic processing and apoptosis, which suggests BDNF may be an important regulator of Aβ production”
BackgroundDoes the term ‘trophic’ actually mean anti-amyloidogenic? The case of NGF
Calissano, P., Amadoro, G., Matrone, C., Ciafrè, S., Marolda, R., Corsetti, V., Ciotti, M. T., Mercanti, D., Luzio, A. D., Severini, C., et al. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.38 · Cited by 39
Self-citationDing, X.-W., Li, R., Geetha, T., Tao, Y.-X., & Babu, J. R. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165858 · Cited by 36
Xu, D. C., Sas‐Nowosielska, H., Donahue, G., Huang, H., Pourshafie, N., Good, C. R., & Berger, S. L. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01696-6 · Cited by 36
“BDNF reduces Aβ production [49] by promoting α-secretase activity to the exclusion of β-secretase activity [47, 48] We find that EP300/ CBP knockdown reduces BDNF expression, suggesting it could be a candidate for amyloid-targeting therapeutic approaches.”
BackgroundAChE as a spark in the Alzheimer’s blaze – Antagonizing effect of a cyclized variant
Behl, T., Kaur, I., Sehgal, A., Singh, S., Sharma, N., Gupta, S., Albratty, M., Najmi, A., Alhazmi, H. A., & BUNGAU, S. G. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101787 · Cited by 37
Naumann, N., Alpár, A., Ueberham, U., Arendt, T., & Gärtner, U. (2010) · Hippocampus · doi:10.1002/hipo.20693 · Cited by 36
“Interestingly, enriched housing or physical activity has been shown to reduce Abeta levels and deposition in transgenic mice expressing mutated hAPP (Lazarov et al., 2005; Ambrée et al., 2006; Um et al., 2008).”
BackgroundInfluentialMoya‐Alvarado, G., Guerra, M. V., Tiburcio, R., Bravo, E., & Bronfman, F. C. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105796 · Cited by 36
Saadipour, K., Manucat-Tan, N. B., Lim, Y. P., Keating, D. J., Smith, K. S., Zhong, J., Liao, H., Bobrovskaya, L., Wang, Y., Chao, M. V., et al. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14206 · Cited by 35
“Previous works have indicated that nerve growth factor (NGF) and BDNF withdrawal from neurons enhanced APP processing (Matrone et al. 2008; Nikolaev et al. 2009).”
BackgroundCognitive Issues in the Older Adult
Ciolek, C. H., & Lee, S. Y. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-60912-8.00019-1 · Cited by 47
Rosa, L. R. L., Perrone, L., Nielsen, M. S., Calissano, P., Andersen, O. M., & Matrone, C. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00109 · Cited by 31
“Hippocampal neurons were prepared from embryonic day 17/18 (E17/18) mice as previously reported (Matrone et al., 2008, 2009).”
MethodSelf-citationThe inorganic perspectives of neurotrophins and Alzheimer's disease
Travaglia, A., Pietropaolo, A., Mendola, D. L., Nicoletti, V. G., & Rizzarelli, E. (2011) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2011.10.017 · Cited by 35
Growth factor treatment to overcome Alzheimer's dysfunctional signaling
Lauzon, M.-A., Daviau, A., Marcos, B., & Faucheux, N. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.02.018 · Cited by 30
Liu, Y.-H., Jiao, S., Wang, Y., Bu, X., Yao, X., Xiang, Y., Wang, Q.-H., Wang, L., Deng, J., Li, J., et al. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8804-8 · Cited by 31
“According to previous studies, we propose that the protective effects of BDNF in AD might occur in three ways: the first is the neurotrophic property of BDNF to improve cognition; the second is that BDNF promotes the non-amyloidgenic process in the brain, thus attenuating AD pathogenesis [31, 32]; the third is that BD…”
Changes in acetylcholinesterase expression are associated with altered presenilin-1 levels
Silveyra, M. X., García‐Ayllón, M., Serra‐Basante, C., Mazzoni, V., García‐Gutiérrez, M. S., Manzanares, J., Culvenor, J. G., & Sáez‐Valero, J. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.04.006 · Cited by 33
Sertad1 Plays an Essential Role in Developmentaland Pathological Neuron Death
Biswas, S. C., Zhang, Y., Iyirhiaro, G. O., Willett, R. T., González, Y. R., Cregan, S. P., Slack, R. S., Park, D. S., & Greene, L. A. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.6421-09.2010 · Cited by 34
“…between the molecular mechanisms of neuron death induced by NGF deprivation, DNA damage, and A exposure (Greene et al., 2007), and recent findings support a mechanism in which neuron death triggered by NGF deprivation is mediated by elevated production and release of A (Matrone et al., 2008a,b).”
Background
Metadata
- Authors
- Matrone, C., Ciotti, M. T., Mercanti, D., Marolda, R., & Calissano, P.
- Affiliations
- Institute of Neurobiology and Molecular Medicine (IT)
- Corresponding author
- Calissano, Pietro
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2008-09-02
- Volume
- 105
- Issue
- 35
- Pages
- 13139-13144
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2525562
- OpenAlex
- W2103126447
- Cited by
- 169
- References
- 24
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 9 · 2023: 6 · 2022: 17 · 2021: 13 · 2020: 8 · 2019: 10 · 2018: 7 · 2017: 9 · 2016: 7 · 2015: 7 · 2014: 9 · 2013: 5 · 2012: 16
- FWCI
- 7.24
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Regione Lazio
- National Institute on Aging (R01AG025970)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Keywords
- nerve growth factor, brain-derived neurotrophic factor, neurotrophic signaling, amyloidogenic pathway, amyloid-beta production, hippocampal neurons, neuronal apoptosis, presenilin 1, APP C-terminal fragments, beta-secretase inhibitors, gamma-secretase inhibitors, Alzheimer's disease
- MeSH terms
- Animals, Antibodies, Cell Extracts, Cell Nucleus, Enzyme Inhibitors, Female, Hippocampus, Neurons, Pregnancy, Blotting, Western, Signal Transduction, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Cell Death, Rats, Wistar, Brain-Derived Neurotrophic Factor, Nerve Growth Factor, Serum, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.